Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


04.12.2017

1 AIDS
1 Am J Gastroenterol
2 BMC Gastroenterol
4 BMJ
3 Clin Infect Dis
2 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
2 Gastroenterology
2 Gut
11 Hepatology
1 Int J Cancer
4 J Hepatol
1 J Immunol
2 J Infect Dis
13 J Viral Hepat
3 J Virol
1 Lancet Glob Health
3 Lancet Infect Dis
1 PLoS Med
4 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Transplantation
3 Vaccine
1 Virology
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. LI F, Ma L, Feng Y, Ruan Y, et al
    HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001702.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. FUKUI N, Golabi P, Otgonsuren M, Mishra A, et al
    Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States.
    Am J Gastroenterol. 2017;112:1700-1708.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  3. BARBOSA MED, Zaninotto AL, de Campos Mazo DF, Pessoa MG, et al
    Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin.
    BMC Gastroenterol. 2017;17:122.
    PubMed     Text format     Abstract available

  4. PERAZZO H, Jorge MJ, Silva JC, Avellar AM, et al
    Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.
    BMC Gastroenterol. 2017;17:119.
    PubMed     Text format     Abstract available


    BMJ

  5. RIMMER A
    Individual clinicians were culpable in blood scandal, says former health secretary.
    BMJ. 2017;358:j4121.
    PubMed     Text format    

  6. STAFFORD N
    Sofosbuvir faces fresh patent challenge in Europe.
    BMJ. 2017;356:j1632.
    PubMed     Text format    

  7. DYER C
    Victims of blood contamination win right to sue government.
    BMJ. 2017;358:j4504.
    PubMed     Text format    

  8. RIMMER A
    Former health secretary is still pushing for justice over contaminated blood scandal.
    BMJ. 2017;358:j4113.
    PubMed     Text format    


    Clin Infect Dis

  9. ROCKSTROH JK
    Is HCV elimination in well-defined patient groups possible?
    Clin Infect Dis. 2017 Nov 23. pii: 4654730. doi: 10.1093/cid/cix1010.
    PubMed     Text format    

  10. BOEREKAMPS A, Newsum AM, Smit C, Arends JE, et al
    High treatment uptake in HIV/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands.
    Clin Infect Dis. 2017 Nov 23. pii: 4654728. doi: 10.1093/cid/cix1004.
    PubMed     Text format     Abstract available

  11. BOEREKAMPS A, Van den Berk GE, Fanny LN, Leyten EM, et al
    Declining HCV incidence in Dutch HIV positive men who have sex with men after unrestricted access to HCV therapy.
    Clin Infect Dis. 2017 Nov 23. pii: 4654729. doi: 10.1093/cid/cix1007.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  12. HOVAIDA M, Torrazza-Perez E, McCarthy D
    Liver Function Tests "Gone Viral": Acute Hepatitis of Uncertain Cause.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4849.
    PubMed     Text format    

  13. KWAK YE, Stein SM, Lim JK
    Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Dig Dis Sci. 2017 Nov 24. pii: 10.1007/s10620-017-4850.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  14. PANG Q, Zhou L, Qu K, Cui RX, et al
    Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.
    Eur J Gastroenterol Hepatol. 2018;30:60-70.
    PubMed     Text format     Abstract available

  15. LIN Z, Liang J, Zhu J, Hu C, et al
    Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 Nov 29. doi: 10.1097/MEG.0000000000001023.
    PubMed     Text format     Abstract available


    Gastroenterology

  16. LIU CJ, Chuang WL, Sheen IS, Wang HY, et al
    Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36369.
    PubMed     Text format     Abstract available

  17. DEBING Y, Schmid MA, Neyts J
    New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay Stack.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36372.
    PubMed     Text format    


    Gut

  18. CHU CM, Liaw YF
    Prognosis of immune-tolerant phase chronic hepatitis B.
    Gut. 2017 Nov 25. pii: gutjnl-2017-315603. doi: 10.1136/gutjnl-2017-315603.
    PubMed     Text format    

  19. WANG X, Yan Y, Gan T, Yang X, et al
    A trivalent HCV vaccine elicits broad and synergistic polyclonal antibody response in mice and rhesus monkey.
    Gut. 2017 Nov 27. pii: gutjnl-2017-314870. doi: 10.1136/gutjnl-2017-314870.
    PubMed     Text format     Abstract available


    Hepatology

  20. HARRINGTON PR, Komatsu TE, Deming DJ, Donaldson EF, et al
    Impact of Hepatitis C Virus Polymorphisms on Direct-Acting Antiviral Treatment Efficacy: Regulatory Analyses and Perspectives.
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29693.
    PubMed     Text format     Abstract available

  21. SINGH AK, Rooge SB, Varshney A, Vasudevan M, et al
    Global micro RNA expression profiling in the liver biopsies of Hepatitis B Virus infected patients suggests specific miRNA signatures for viral persistence and hepatocellular injury.
    Hepatology. 2017 Nov 30. doi: 10.1002/hep.29690.
    PubMed     Text format     Abstract available

  22. GERMANIDIS G, Hytiroglou P, Vassiliadis T, Speletas M, et al
    Checkpoint modulation in chronic hepatitis B: From hypothesis to approval.
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29695.
    PubMed     Text format    

  23. SAAB S, Le L, Saggi S, Sundaram V, et al
    Towards the Elimination of Hepatitis C in the United States.
    Hepatology. 2017 Nov 27. doi: 10.1002/hep.29685.
    PubMed     Text format     Abstract available

  24. WANG W, Wang Y, Qu C, Wang S, et al
    The RNA genome of hepatitis E virus robustly triggers antiviral interferon response.
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29702.
    PubMed     Text format     Abstract available

  25. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Lower effectiveness of hepatitis C antiviral treatment in patients with hepatocellular carcinoma: Is active tumor the clue?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29700.
    PubMed     Text format    

  26. JI F, Yeo YH, Wei MT, Wei B, et al
    Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29701.
    PubMed     Text format    

  27. CHANG FM, Wang YP, Lu CL
    Reply: Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29686.
    PubMed     Text format    

  28. LIN CY
    Statins and risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: Methodological issues.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29687.
    PubMed     Text format    

  29. CHEN X, Oidovsambuu O, Liu P, Grosely R, et al
    A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.
    Hepatology. 2017;66:1739-1749.
    PubMed     Text format     Abstract available

  30. ALNUAIMI K, Lavole J, Lascoux-Combes C, Afonso AR, et al
    Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine.
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29697.
    PubMed     Text format    


    Int J Cancer

  31. LIU X, Baecker A, Wu M, Zhou JY, et al
    Interaction between Tobacco Smoking and Hepatitis B Virus Infection on the Risk of Liver Cancer in a Chinese Population.
    Int J Cancer. 2017 Nov 28. doi: 10.1002/ijc.31181.
    PubMed     Text format     Abstract available


    J Hepatol

  32. KUBILIUN M, Patel SJ, Hur C, Dienstag JL, et al
    Early liver transplantation for alcoholic hepatitis: Ready for primetime?
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32452.
    PubMed     Text format    

  33. FORREST EH, Atkinson SR, Richardson P, Masson S, et al
    Application of Prognostic Scores in The Stopah Trial: Discriminant Function is no Longer the Optimal Scoring System in Alcoholic Hepatitis.
    J Hepatol. 2017 Nov 21. pii: S0168-8278(17)32440.
    PubMed     Text format     Abstract available

  34. HUPA KL, Deterding K, Port K, Kimmann M, et al
    In Reply to: EASL RECOMMENDATIONS ON TREATMENT OF HEPATITIS C 2016 "Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?"
    J Hepatol. 2017 Nov 21. pii: S0168-8278(17)32443.
    PubMed     Text format    

  35. HARTL J, Ehlken H, Sebode M, Peiseler M, et al
    Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    J Hepatol. 2017 Nov 24. pii: S0168-8278(17)32445.
    PubMed     Text format     Abstract available


    J Immunol

  36. OBAJEMU AA, Rao N, Dilley KA, Vargas JM, et al
    IFN-lambda4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
    J Immunol. 2017;199:3808-3820.
    PubMed     Text format     Abstract available


    J Infect Dis

  37. BOON D, Redd AD, Layendecker O, Engle R, et al
    Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda.
    J Infect Dis. 2017 Nov 23. pii: 4653785. doi: 10.1093.
    PubMed     Text format     Abstract available

  38. CHEN HL, Wen WH, Chang MH
    Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    J Viral Hepat

  39. JENG WJ, Chen YC, Liaw YF
    Great and rapid HBsAg decline in patients with on-treatment hepatitis flare in early phase of potent antiviral therapy.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12833.
    PubMed     Text format     Abstract available

  40. YOUNOSSI ZM, Stepanova M, Schwarz KB, Wirth S, et al
    Quality of Life in Adolescents with Hepatitis C Treated with Sofosbuvir and Ribavirin.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12830.
    PubMed     Text format     Abstract available

  41. LEE HR, Cho YY, Lee GY, You DG, et al
    A direct role for hepatitis B virus X protein in inducing mitochondrial membrane permeabilization.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12831.
    PubMed     Text format     Abstract available

  42. ALAVI M, Janjua NZ, Chong M, Grebely J, et al
    Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison.
    J Viral Hepat. 2017 Nov 30. doi: 10.1111/jvh.12837.
    PubMed     Text format     Abstract available

  43. LIU J, Zhang S, Liu M, Wang Q, et al
    Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population-based cross-sectional study.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12829.
    PubMed     Text format     Abstract available

  44. CHEN Y, Xie C, Zhang Y, Li Y, et al
    Knowledge regarding Hepatitis B Mother-to-child Transmission among Healthcare Workers in South China.
    J Viral Hepat. 2017 Nov 30. doi: 10.1111/jvh.12839.
    PubMed     Text format     Abstract available

  45. NAM JY, Chang Y, Cho H, Kang SH, et al
    Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B.
    J Viral Hepat. 2017 Dec 1. doi: 10.1111/jvh.12838.
    PubMed     Text format     Abstract available

  46. CARLTON-SMITH C, Holmes JA, Naggie S, Lidofsky A, et al
    IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR.
    J Viral Hepat. 2017 Nov 29. doi: 10.1111/jvh.12836.
    PubMed     Text format     Abstract available

  47. TANAKA J, Akita T, Ohisa M, Sakamune K, et al
    Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12828.
    PubMed     Text format     Abstract available

  48. TAMORI A, Abiru S, Enomoto H, Kioka K, et al
    Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.
    J Viral Hepat. 2017 Nov 30. doi: 10.1111/jvh.12840.
    PubMed     Text format     Abstract available

  49. HU Y, Xu C, Xu B, Hu L, et al
    Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: a multicenter prospective cohort study.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12834.
    PubMed     Text format     Abstract available

  50. WANG Y, Liang X, Yang J, Wang H, et al
    Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of non-advanced liver fibrosis for chronic hepatitis B.
    J Viral Hepat. 2017 Nov 29. doi: 10.1111/jvh.12835.
    PubMed     Text format     Abstract available

  51. HSU YC, Ho HJ, Lee TY, Huang YT, et al
    Temporal Trend and Risk Determinants of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Entecavir or Tenofovir.
    J Viral Hepat. 2017 Nov 28. doi: 10.1111/jvh.12832.
    PubMed     Text format     Abstract available


    J Virol

  52. YANG Z, Wang X, Chi X, Zhao F, et al
    Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection".
    J Virol. 2017;91.
    PubMed     Text format    

  53. KWEI K, Tang X, Lok AS, Sureau C, et al
    Correction for Kwei et al., "Impaired Virion Secretion by Hepatitis B Virus Immune Escape Mutants and Its Rescue by Wild-Type Envelope Proteins or a Second-Site Mutation".
    J Virol. 2017;91.
    PubMed     Text format    

  54. KIM H, Bose SK, Meyer K, Ray R, et al
    Correction for Kim et al., "Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis".
    J Virol. 2017;91.
    PubMed     Text format    


    Lancet Glob Health

  55. BAUDIN M, Jumaa AM, Jomma HJ, Karsany MS, et al
    Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study.
    Lancet Glob Health. 2016 Sep 27. pii: S2214-109X(16)30176.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  56. YU G, Li GF, Zhou HH
    Proton-pump inhibitors and glecaprevir plus pibrentasvir in HCV infection.
    Lancet Infect Dis. 2017;17:1239-1240.
    PubMed     Text format    

  57. FORNS X, Mensa FJ
    Proton-pump inhibitors and glecaprevir plus pibrentasvir in HCV infection - Authors' reply.
    Lancet Infect Dis. 2017;17:1240.
    PubMed     Text format    

  58. VIKSE J, Klos J, Berg A
    A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusions.
    Lancet Infect Dis. 2017;17:1318.
    PubMed     Text format    


    PLoS Med

  59. SOLOMON SS, McFall AM, Lucas GM, Srikrishnan AK, et al
    Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    PLoS Med. 2017;14:e1002460.
    PubMed     Text format     Abstract available


    PLoS One

  60. CARLUCCI JG, Farooq SA, Sizemore L, Rickles M, et al
    Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.
    PLoS One. 2017;12:e0188624.
    PubMed     Text format     Abstract available

  61. LEE IC, Chau GY, Yeh YC, Chao Y, et al
    Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.
    PLoS One. 2017;12:e0188552.
    PubMed     Text format     Abstract available

  62. SPINA A, Lenglet A, Beversluis D, de Jong M, et al
    A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016-2017.
    PLoS One. 2017;12:e0188240.
    PubMed     Text format     Abstract available

  63. BRAGA ACS, Carneiro BM, Batista MN, Akinaga MM, et al
    Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity.
    PLoS One. 2017;12:e0188467.
    PubMed     Text format     Abstract available


    PLoS Pathog

  64. KUMTHIP K, Yang D, Li NL, Zhang Y, et al
    Pivotal role for the ESCRT-II complex subunit EAP30/SNF8 in IRF3-dependent innate antiviral defense.
    PLoS Pathog. 2017;13:e1006713.
    PubMed     Text format     Abstract available

  65. YU Y, Scheel TKH, Luna JM, Chung H, et al
    miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence.
    PLoS Pathog. 2017;13:e1006694.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  66. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
    Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
    PubMed     Text format     Abstract available


    Transplantation

  67. HOLSCHER CM, Durand CM, Desai NM
    Expanding the Use of Organs from Hepatitis C-Viremic Donors: The Evidence Continues to Build.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002032.
    PubMed     Text format    


    Vaccine

  68. MORO PL, Zheteyeva Y, Barash F, Lewis P, et al
    Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31603.
    PubMed     Text format     Abstract available

  69. CHEN Y, Zhou CL, Zhang XJ, Hao ZY, et al
    Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
    Vaccine. 2017 Nov 25. pii: S0264-410X(17)31600.
    PubMed     Text format     Abstract available

  70. CHILDS L, Roesel S, Tohme RA
    Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31591.
    PubMed     Text format     Abstract available


    Virology

  71. CAMUS G, Xu S, Han B, Lu J, et al
    Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
    Virology. 2017;514:134-141.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  72. SCHLEVOGT B, Deterding K, Port K, Siederdissen CHZ, et al
    Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up.
    Z Gastroenterol. 2017;55:848-856.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: